At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
t:slim X2 insulin pump with Tandem Freedom Algorithmdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tandem Freedom Feasibility Study 1
In Brief
A clinical study evaluating t:slim X2 insulin pump with Tandem Freedom Algorithm for Diabetes Mellitus, Type 1. Completed, enrolled 10 participants across 1 site.
Detailed Summary
This feasibility study is a prospective, single arm study evaluating the Tandem Freedom system in adults with type 1 diabetes. Existing Control-IQ technology users will use Control-IQ technology at home for a 1 week run-in, then will use Tandem Freedom in a supervised hotel setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesNew Zealand
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedMay 2024
Enrollment StartMay 2024
Primary CompletionJun 2024
TodayJul 2026
First PostedMay 24, 2024
Enrollment StartMay 29, 2024
Primary CompletionJun 10, 2024
TodayJul 2, 2026
Enrollment to primary: 11 daysPosted 2.1 years ago
Interventions
t:slim X2 insulin pump with Tandem Freedom Algorithmdevice
Participants will use the Tandem Freedom system for one day with insulin boluses and one day without insulin boluses.